David R. Gagnon, MD, PhD
Research Professor
Boston University School of Public Health
Dept of Biostatistics

MD, Tufts University
MPH, Boston University
PhD, Boston University School of Public Health

David Gagnon, MD MPH PhD is Associate Professor of Biostatistics. Dr. Gagnon is a biostatistician for the Framingham Foot Study and a senior biostatistician for the Massachusetts Veterans Epidemiology Research and Information Center [MAVERIC] located at the Boston VA hospital. He currently teaches Categorical Data Analysis [BS821], Advanced Methods in Statistical Computing [BS822] and Applications of Statistical Methods in Clinical Research [BS775].

Dr Gagnon's research interests are in the areas of pharmacoepidemiology, longitudinal data analysis, survival analysis and statistical computing.

Personnel agreement for the research services of David Gagnon
10/01/2015 - 06/30/2017 (PI)
VA Boston Healthcare System

Determinants of fall-related bleeding among older adults with atrial fibrillation
08/15/2014 - 07/31/2015 (PI)
New York University School of Medicine NIH NIA

Personnel agreement for the research services of David Gagnon
11/01/2011 - 07/31/2015 (PI)
VA Boston Healthcare System

Determinants of Fall-related Bleeding Among Older Adults with Atrial Fibrillation
09/01/2013 - 07/31/2014 (PI)
The Brigham and Women's Hospital, Inc. NIH NIA

Foot Disorders, Pain and Physical Disability in Elders
09/01/2002 - 08/31/2013 (PI)
Hebrew Rehabilitation Center for the Aged NIH NIAMS
5 R01 AR047853 08

Foot Disorders, Pain and Physical Disability in Elders
09/01/2002 - 08/31/2013 (PI)
Hebrew Rehabilitation Center For Aged, Inc. NIH NIAMS

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Wiltsey Stirman S, Finley EP, Shields N, Cook J, Haine-Schlagel R, Burgess JF, Dimeff L, Koerner K, Suvak M, Gutner CA, Gagnon D, Masina T, Beristianos M, Mallard K, Ramirez V, Monson C. Improving and sustaining delivery of CPT for PTSD in mental health systems: a cluster randomized trial. Implement Sci. 2017 Mar 06; 12(1):32.View Related Profiles. PMID: 28264720; DOI: 10.1186/s13012-017-0544-5;.
  2. Wimmer NJ, Dufour AB, Cho K, Gagnon DR, Quach L, Ly S, Do JM, Ostrowski S, Michael Gaziano J, Faxon DP, Kinlay S. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1176-1184. PMID: 27860195; DOI: 10.1002/ccd.26831;.
  3. Ngwa JS, Cabral HJ, Cheng DM, Pencina MJ, Gagnon DR, LaValley MP, Cupples LA. A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study. BMC Med Res Methodol. 2016 Nov 03; 16(1):148.View Related Profiles. PMID: 27809784.
  4. Barber C, Gagnon D, Fonda J, Cho K, Hermos J, Miller M. Assessing the impact of prescribing directives on opioid prescribing practices among Veterans Health Administration providers. Pharmacoepidemiol Drug Saf. 2017 Jan; 26(1):40-46.View Related Profiles. PMID: 27530106; DOI: 10.1002/pds.4066;.
  5. Shantakumar S, Nordstrom BL, Djousse L, Hall SA, Gagnon DR, Fraeman KH, van Herk-Sukel M, Chagin K, Nelson J. Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network. Cancer Chemother Pharmacol. 2016 Sep; 78(3):559-66. PMID: 27438066; PMCID: PMC5010603; DOI: 10.1007/s00280-016-3112-9;.
  6. Morse LR, Nguyen N, Battaglino RA, Guarino AJ, Gagnon DR, Zafonte R, Garshick E. Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study. Osteoporos Int. 2016 Dec; 27(12):3503-3511.View Related Profiles. PMID: 27412619.
  7. Dodson JA, Petrone A, Gagnon DR, Tinetti ME, Krumholz HM, Gaziano JM. Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial Fibrillation. JAMA Cardiol. 2016 Apr 01; 1(1):65-72. PMID: 27437657; DOI: 10.1001/jamacardio.2015.0345;.
  8. Thukkani AK, Agrawal K, Prince L, Smoot KJ, Dufour AB, Cho K, Gagnon DR, Sokolovskaya G, Ly S, Temiyasathit S, Faxon DP, Gaziano JM, Kinlay S. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. J Am Coll Cardiol. 2015 Sep 8; 66(10):1091-101. PMID: 26337986; PMCID: PMC4578293; DOI: 10.1016/j.jacc.2015.06.1339;.
  9. Siddiqi OK, Smoot KJ, Dufour AB, Cho K, Young M, Gagnon DR, Ly S, Temiyasathit S, Faxon DP, Gaziano JM, Kinlay S. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease. Heart. 2015 Oct; 101(19):1569-76.View Related Profiles. PMID: 26209334; PMCID: PMC4580134; DOI: 10.1136/heartjnl-2014-307168;.
  10. Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, Gagnon DR. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015 Apr; 175(4):608-15.View Related Profiles. PMID: 25686208; DOI: 10.1001/jamainternmed.2014.8071;.
Showing 10 of 99 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 99 publications over 28 distinct years, with a maximum of 11 publications in 2008

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Gagnon's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department